-
1 Comment
Fukuda Denshi Co., Ltd is currently in a long term uptrend where the price is trading 13.9% above its 200 day moving average.
From a valuation standpoint, the stock is 98.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.
Fukuda Denshi Co., Ltd's total revenue rose by 27.9% to $36B since the same quarter in the previous year.
Its net income has increased by 145.7% to $4B since the same quarter in the previous year.
Based on the above factors, Fukuda Denshi Co., Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| ISIN | JP3806000000 |
| CurrencyCode | JPY |
| Exchange | TSE |
| Beta | 0.28 |
|---|---|
| PE Ratio | 7.56 |
| Target Price | 4400 |
| Dividend Yield | 2.7% |
| Market Cap | 123B |
Fukuda Denshi Co., Ltd. engages in the manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph and stress test products; patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems, such as data management software. The company was founded in 1939 and is based in Tokyo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6960.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
